Large language models are helping scientists to converse with artificial intelligence and even to generate potential drug targets.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
02 May 2023
In the version of this article initially published, Andrew Beam’s roles were incorrectly described and have now been updated.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Savage, N. Drug discovery companies are customizing ChatGPT: here’s how. Nat Biotechnol 41, 585–586 (2023). https://doi.org/10.1038/s41587-023-01788-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-023-01788-7